|
|
||||||||
Brief Report |
Received June 11, 2004; revised November 24, 2004; accepted December 7, 2004. From the Depts. of Psychiatry and Neurology, Emory University School of Medicine, Atlanta, GA 30329. Send correspondence and reprint requests to Rita D. Jewart, Ph.D., Wesley Woods Health Center, 1841 Clifton Road NE, Atlanta, GA 30329. e-mail: rjewart{at}emory.edu
© 2005 American Association for Geriatric Psychiatry
Objective: Authors evaluated the cognitive, neurophysiologic, and behavioral effects of incontinence medications in patients with Alzheimer disease (AD). Methods: Nine patients were evaluated, both on and off incontinence medication, for cognitive status, neuropsychiatric status, activities of daily living, and serum anticholinergic level. Caregivers were interviewed to evaluate behavioral status and caregiver burden. Results: Patients showed better performance on specific measures of cognition and behavior when not taking medication for incontinence. A significant, inverse correlation was found between mental status and anticholinergic level. Conclusion: Although the sample size was small, the findings suggest that, in patients with AD, incontinence medications with anticholinergic properties may have detrimental effects on mental status and behavior.
Key Words: Alzheimer Disease Incontinence Medication Side Effects
This article has been cited by other articles:
![]() |
H. Joshi and M. Parle Brahmi rasayana Improves Learning and Memory in Mice. Evid. Based Complement. Altern. Med., March 1, 2006; 3(1): 79 - 85. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ALL ISSUES | SEARCH | TABLE OF CONTENTS |